Quantcast

Latest Unigene Laboratories Stories

2011-09-19 08:07:26

Demonstrated superior efficacy to intranasal calcitonin with equivalent safety -- could represent new osteoporosis treatment option -- calcitonin has 30-year record of safety and efficacy but lack of oral form has limited its use Tarsa Therapeutics on Sunday presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis. These data were presented...

2011-07-12 06:30:00

PHILADELPHIA, July 12, 2011 /PRNewswire/ -- Tarsa Therapeutics today reported progress in its two ongoing clinical development programs for its oral recombinant salmon calcitonin for the treatment and prevention of postmenopausal osteoporosis. Patient enrollment in the Phase II osteoporosis prevention trial has been completed, and the full set of data from the Phase III ORACAL trial has been accepted for an oral presentation at the American Society for Bone and Mineral Research (ASBMR)...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'